Market Size of Global Colposcopy Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 7.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Colposcopy Devices Market Analysis
The global colposcopy devices market is anticipated to grow with a CAGR of nearly 7.1% during the forecast period.
Due to the high transmission rate of COVID-19 and lack of treatment, many countries have suffered and are continuing to bear a significant burden on both their economies and healthcare systems. Many countries have been in lockdown and have suspended trades with other countries, implemented travel restrictions, etc., leading to declining in market capitalizations of major companies across the world, along with a decline in industrial production, sales of automobiles, and other businesses. The lockdown measures across the world have resulted in decreased public mobility and have also impacted the cancer therapeutics and diagnostics industry significantly. A study published in the Lancet in March 2021 revealed a high mortality rate for COVID-19 patients with cancer. Patients with cancer appear to be at higher risk of receiving adverse effects from infection, including a greater need for support ventilators. A cancer diagnosis can be delayed as screening and diagnostic services have been reduced or suspended in many countries, and patients, avoiding the risk of infection, have been very hesitant to introduce to healthcare services. Therapies have been modified to reduce the potential exposure of patients with cancer to SARS-CoV-2 and to reduce the risk during surgery or radiation therapy. Certain aspects of ongoing care have been reduced to enable the health systems to respond to the COVID-19 epidemic, resulting in patients receiving far less care or delay. hence, it is observed that COVID-19 hurts the market studied.
As per the National Cancer Institute data published in 2022, cervical cancer cases are estimated to reach 14,100 in the year 2022 in the United States. Due to the rising burden of cervical cancer, developing countries are focusing more on increasing the reach of cancer screening programs, which in turn is expected to trigger the adoption of colposcopes. In addition, technological advancement such as the integration of digital platforms with colposcopy equipment is working in favor of the overall market. Integration is boding well for high-resolution imaging devices, which are likely to replace traditional colposcopes, thereby influencing market dynamics.
However, reimbursement policy coverage in developing countries may hamper the growth of the market.
